These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7593547)
21. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association. Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386 [TBL] [Abstract][Full Text] [Related]
22. HLA class II transgenic mice authenticate restriction of myelin oligodendrocyte glycoprotein-specific immune response implicated in multiple sclerosis pathogenesis. Khare M; Rodriguez M; David CS Int Immunol; 2003 Apr; 15(4):535-46. PubMed ID: 12663683 [TBL] [Abstract][Full Text] [Related]
23. Structure of the human myelin/oligodendrocyte glycoprotein gene and multiple alternative spliced isoforms. Pham-Dinh D; Della Gaspera B; Kerlero de Rosbo N; Dautigny A Genomics; 1995 Sep; 29(2):345-52. PubMed ID: 8666381 [TBL] [Abstract][Full Text] [Related]
24. Genetic variations and humoral immune responses to myelin oligodendroglia glycoprotein in adult phenotypes of X-linked adrenoleukodystrophy. Schmidt S; Marrosu GM; Kölsch H; Haase CG; Ferenczik S; Sokolowski P; Köhler W; Schmidt M; Papassotiropoulos A; Heun R; Grosse-Wilde H; Klockgether T J Neuroimmunol; 2003 Feb; 135(1-2):148-53. PubMed ID: 12576235 [TBL] [Abstract][Full Text] [Related]
25. [Myelin oligodendrogliocyte glycoprotein: the structure, functions, role in pathogenesis of demyelinating disorders]. Chekhonin VP; Semenova AV; Gurina OI; Dmitrieva TB Biomed Khim; 2003; 49(5):411-23. PubMed ID: 16119093 [TBL] [Abstract][Full Text] [Related]
26. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis. Karni A; Bakimer-Kleiner R; Abramsky O; Ben-Nun A Arch Neurol; 1999 Mar; 56(3):311-5. PubMed ID: 10190821 [TBL] [Abstract][Full Text] [Related]
27. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Lindert RB; Haase CG; Brehm U; Linington C; Wekerle H; Hohlfeld R Brain; 1999 Nov; 122 ( Pt 11)():2089-100. PubMed ID: 10545394 [TBL] [Abstract][Full Text] [Related]
28. Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. Hilton AA; Slavin AJ; Hilton DJ; Bernard CC J Neurochem; 1995 Jul; 65(1):309-18. PubMed ID: 7790876 [TBL] [Abstract][Full Text] [Related]
29. The structure and function of myelin oligodendrocyte glycoprotein. Johns TG; Bernard CC J Neurochem; 1999 Jan; 72(1):1-9. PubMed ID: 9886048 [TBL] [Abstract][Full Text] [Related]
30. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis. Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459 [TBL] [Abstract][Full Text] [Related]
31. Reading disability and chromosome 6p21.3: evaluation of MOG as a candidate gene. Smith SD; Kelley PM; Askew JW; Hoover DM; Deffenbacher KE; Gayán J; Brower AM; Olson RK J Learn Disabil; 2001; 34(6):512-9. PubMed ID: 15503566 [TBL] [Abstract][Full Text] [Related]
32. Myelin/oligodendrocyte glycoprotein is alternatively spliced in humans but not mice. Ballenthin PA; Gardinier MV J Neurosci Res; 1996 Oct; 46(2):271-81. PubMed ID: 8915905 [TBL] [Abstract][Full Text] [Related]
33. The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study. Koehler NK; Genain CP; Giesser B; Hauser SL J Immunol; 2002 Jun; 168(11):5920-7. PubMed ID: 12023398 [TBL] [Abstract][Full Text] [Related]
35. Linkage disequilibrium analysis of polymorphisms in the gene for myelin oligodendrocyte glycoprotein in Tourette's syndrome patients from a Chinese sample. Huang Y; Li T; Wang Y; Ansar J; Lanting G; Liu X; Zhao JH; Hu X; Sham PC; Collier D Am J Med Genet B Neuropsychiatr Genet; 2004 Jan; 124B(1):76-80. PubMed ID: 14681920 [TBL] [Abstract][Full Text] [Related]
36. The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Clements CS; Reid HH; Beddoe T; Tynan FE; Perugini MA; Johns TG; Bernard CC; Rossjohn J Proc Natl Acad Sci U S A; 2003 Sep; 100(19):11059-64. PubMed ID: 12960396 [TBL] [Abstract][Full Text] [Related]
37. Myelin Oligodendrocyte Glycoprotein and Multiple Sclerosis. Androutsou ME; Tapeinou A; Vlamis-Gardikas A; Tselios T Med Chem; 2018 Feb; 14(2):120-128. PubMed ID: 28875859 [TBL] [Abstract][Full Text] [Related]
38. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein. Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072 [TBL] [Abstract][Full Text] [Related]
39. Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia. Zai G; King N; Wigg K; Couto J; Wong GW; Honer WG; Barr CL; Kennedy JL Genes Brain Behav; 2005 Feb; 4(1):2-9. PubMed ID: 15660663 [TBL] [Abstract][Full Text] [Related]
40. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]